<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="result">
            <roleset id="result.01" name="" wordnet="2">
                <roles>
                    <role n="0" descr="Theme, prior condition &#x0A;" />
                    <role n="1" descr="Goal, end condition&#x0A;" />
                </roles>
                <example src="EGRAM" no="0">
                    <text>A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling that can result in a Clr phenotype is conferred by either an activated egl-15 or a lf clr-1 mutation.</text>
                    <arg n="0">A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="EGRAM" no="1">
                    <text>A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling that has resulted in a Clr phenotype is conferred by either an activated egl-15 or a lf clr-1 mutation.</text>
                    <arg n="0">A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="EGRAM" no="2">
                    <text>A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling that has the ability to result in a Clr phenotype is conferred by either an activated egl-15 or a lf clr-1 mutation.</text>
                    <arg n="0">A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="EGRAM" no="3">
                    <text>A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling that is able to result in a Clr phenotype is conferred by either an activated egl-15 or a lf clr-1 mutation.</text>
                    <arg n="0">A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="EGRAM" no="4">
                    <text>A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling that may have resulted in a Clr phenotype is conferred by either an activated egl-15 or a lf clr-1 mutation.</text>
                    <arg n="0">A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="EGRAM" no="5">
                    <text>A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling that resulted in a Clr phenotype is conferred by either an activated egl-15 or a lf clr-1 mutation.</text>
                    <arg n="0">A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="EGRAM" no="6">
                    <text>A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling that results in a Clr phenotype is conferred by either an activated egl-15 or a lf clr-1 mutation.</text>
                    <arg n="0">A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="EGRAM" no="7">
                    <text>A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling, conferred by either an activated egl-15 or a lf clr-1 mutation, can result in a Clr phenotype.</text>
                    <arg n="0">A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="EGRAM" no="8">
                    <text>A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling, conferred by either an activated egl-15 or a lf clr-1 mutation, has resulted in a Clr phenotype.</text>
                    <arg n="0">A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="EGRAM" no="9">
                    <text>A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling, conferred by either an activated egl-15 or a lf clr-1 mutation, has the ability to result in a Clr phenotype.</text>
                    <arg n="0">A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="EGRAM" no="10">
                    <text>A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling, conferred by either an activated egl-15 or a lf clr-1 mutation, is able to result in a Clr phenotype.</text>
                    <arg n="0">A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="EGRAM" no="11">
                    <text>A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling, conferred by either an activated egl-15 or a lf clr-1 mutation, is observed to result in a Clr phenotype.</text>
                    <arg n="0">A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="EGRAM" no="12">
                    <text>A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling, conferred by either an activated egl-15 or a lf clr-1 mutation, may have resulted in a Clr phenotype.</text>
                    <arg n="0">A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="EGRAM" no="13">
                    <text>A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling, conferred by either an activated egl-15 or a lf clr-1 mutation, may result in a Clr phenotype.</text>
                    <arg n="0">A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="EGRAM" no="14">
                    <text>A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling, conferred by either an activated egl-15 or a lf clr-1 mutation, resulted in a Clr phenotype.</text>
                    <arg n="0">A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="EGRAM" no="15">
                    <text>A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling, conferred by either an activated egl-15 or a lf clr-1 mutation, will result in a Clr phenotype.</text>
                    <arg n="0">A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="EGRAM" no="16">
                    <text>Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation are able to result in mRNA species with distinct 5UTRs.</text>
                    <arg n="0">Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with distinct 5UTRs</arg>
                </example>
                <example src="EGRAM" no="17">
                    <text>Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation are observed to result in mRNA species with distinct 5UTRs.</text>
                    <arg n="0">Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with distinct 5UTRs</arg>
                </example>
                <example src="EGRAM" no="18">
                    <text>Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation can result in mRNA species with distinct 5UTRs.</text>
                    <arg n="0">Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with distinct 5UTRs</arg>
                </example>
                <example src="EGRAM" no="19">
                    <text>Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation could have resulted in mRNA species with distinct 5UTRs.</text>
                    <arg n="0">Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with distinct 5UTRs</arg>
                </example>
                <example src="EGRAM" no="20">
                    <text>Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation have resulted in mRNA species with distinct 5UTRs.</text>
                    <arg n="0">Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with distinct 5UTRs</arg>
                </example>
                <example src="EGRAM" no="21">
                    <text>Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation have the ability to result in mRNA species with distinct 5UTRs.</text>
                    <arg n="0">Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with distinct 5UTRs</arg>
                </example>
                <example src="EGRAM" no="22">
                    <text>Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation may have resulted in mRNA species with distinct 5UTRs.</text>
                    <arg n="0">Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with distinct 5UTRs</arg>
                </example>
                <example src="EGRAM" no="23">
                    <text>Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation resulted in mRNA species with distinct 5UTRs.</text>
                    <arg n="0">Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with distinct 5UTRs</arg>
                </example>
                <example src="EGRAM" no="24">
                    <text>Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation will result in mRNA species with distinct 5UTRs.</text>
                    <arg n="0">Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with distinct 5UTRs</arg>
                </example>
                <example src="EGRAM" no="25">
                    <text>Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested, are able to result in mRNA species with distinct 5UTRs.</text>
                    <arg n="0">Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested,</arg>
                    <arg n="1">mRNA species with distinct 5UTRs</arg>
                </example>
                <example src="EGRAM" no="26">
                    <text>Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested, are observed to result in mRNA species with distinct 5UTRs.</text>
                    <arg n="0">Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested,</arg>
                    <arg n="1">mRNA species with distinct 5UTRs</arg>
                </example>
                <example src="EGRAM" no="27">
                    <text>Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested, can result in mRNA species with distinct 5UTRs.</text>
                    <arg n="0">Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested,</arg>
                    <arg n="1">mRNA species with distinct 5UTRs</arg>
                </example>
                <example src="EGRAM" no="28">
                    <text>Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested, could have resulted in mRNA species with distinct 5UTRs.</text>
                    <arg n="0">Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested,</arg>
                    <arg n="1">mRNA species with distinct 5UTRs</arg>
                </example>
                <example src="EGRAM" no="29">
                    <text>Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested, have resulted in mRNA species with distinct 5UTRs.</text>
                    <arg n="0">Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested,</arg>
                    <arg n="1">mRNA species with distinct 5UTRs</arg>
                </example>
                <example src="EGRAM" no="30">
                    <text>Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested, have the ability to result in mRNA species with distinct 5UTRs.</text>
                    <arg n="0">Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested,</arg>
                    <arg n="1">mRNA species with distinct 5UTRs</arg>
                </example>
                <example src="EGRAM" no="31">
                    <text>Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested, may have resulted in mRNA species with distinct 5UTRs.</text>
                    <arg n="0">Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested,</arg>
                    <arg n="1">mRNA species with distinct 5UTRs</arg>
                </example>
                <example src="EGRAM" no="32">
                    <text>Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested, result in mRNA species with distinct 5UTRs.</text>
                    <arg n="0">Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested,</arg>
                    <arg n="1">mRNA species with distinct 5UTRs</arg>
                </example>
                <example src="EGRAM" no="33">
                    <text>Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested, resulted in mRNA species with distinct 5UTRs.</text>
                    <arg n="0">Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested,</arg>
                    <arg n="1">mRNA species with distinct 5UTRs</arg>
                </example>
                <example src="EGRAM" no="34">
                    <text>Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested, will result in mRNA species with distinct 5UTRs.</text>
                    <arg n="0">Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested,</arg>
                    <arg n="1">mRNA species with distinct 5UTRs</arg>
                </example>
                <example src="EGRAM" no="35">
                    <text>Both the 5 and 3 splice site mutations (1060 + 2t--&gt;c and 678-7g--&gt;a, respectively) are able to result in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
                    <arg n="0">Both the 5 and 3 splice site mutations</arg>
                    <arg n="1">high proportions of mature mRNAs containing introns</arg>
                </example>
                <example src="EGRAM" no="36">
                    <text>Both the 5 and 3 splice site mutations (1060 + 2t--&gt;c and 678-7g--&gt;a, respectively) are observed to result in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
                    <arg n="0">Both the 5 and 3 splice site mutations</arg>
                    <arg n="1">high proportions of mature mRNAs containing introns</arg>
                </example>
                <example src="EGRAM" no="37">
                    <text>Both the 5 and 3 splice site mutations (1060 + 2t--&gt;c and 678-7g--&gt;a, respectively) can result in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
                    <arg n="0">Both the 5 and 3 splice site mutations</arg>
                    <arg n="1">high proportions of mature mRNAs containing introns</arg>
                </example>
                <example src="EGRAM" no="38">
                    <text>Both the 5 and 3 splice site mutations (1060 + 2t--&gt;c and 678-7g--&gt;a, respectively) has resulted in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
                    <arg n="0">Both the 5 and 3 splice site mutations</arg>
                    <arg n="1">high proportions of mature mRNAs containing introns</arg>
                </example>
                <example src="EGRAM" no="39">
                    <text>Both the 5 and 3 splice site mutations (1060 + 2t--&gt;c and 678-7g--&gt;a, respectively) have the ability to result in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
                    <arg n="0">Both the 5 and 3 splice site mutations</arg>
                    <arg n="1">high proportions of mature mRNAs containing introns</arg>
                </example>
                <example src="EGRAM" no="40">
                    <text>Both the 5 and 3 splice site mutations (1060 + 2t--&gt;c and 678-7g--&gt;a, respectively) may have resulted in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
                    <arg n="0">Both the 5 and 3 splice site mutations</arg>
                    <arg n="1">high proportions of mature mRNAs containing introns</arg>
                </example>
                <example src="EGRAM" no="41">
                    <text>Both the 5 and 3 splice site mutations (1060 + 2t--&gt;c and 678-7g--&gt;a, respectively) resulted in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
                    <arg n="0">Both the 5 and 3 splice site mutations</arg>
                    <arg n="1">high proportions of mature mRNAs containing introns</arg>
                </example>
                <example src="EGRAM" no="42">
                    <text>Both the 5 and 3 splice site mutations (1060 + 2t--&gt;c and 678-7g--&gt;a, respectively) will result in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
                    <arg n="0">Both the 5 and 3 splice site mutations</arg>
                    <arg n="1">high proportions of mature mRNAs containing introns</arg>
                </example>
                <example src="EGRAM" no="43">
                    <text>Both the 5 and 3 splice site mutations (1060 + 2t--&gt;c and 678-7g--&gt;a, respectively), in contrast, are able to result in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
                    <arg n="0">Both the 5 and 3 splice site mutations</arg>
                    <arg n="1">high proportions of mature mRNAs containing introns</arg>
                </example>
                <example src="EGRAM" no="44">
                    <text>Both the 5 and 3 splice site mutations (1060 + 2t--&gt;c and 678-7g--&gt;a, respectively), in contrast, are observed to result in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
                    <arg n="0">Both the 5 and 3 splice site mutations</arg>
                    <arg n="1">high proportions of mature mRNAs containing introns</arg>
                </example>
                <example src="EGRAM" no="45">
                    <text>Both the 5 and 3 splice site mutations (1060 + 2t--&gt;c and 678-7g--&gt;a, respectively), in contrast, can result in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
                    <arg n="0">Both the 5 and 3 splice site mutations</arg>
                    <arg n="1">high proportions of mature mRNAs containing introns</arg>
                </example>
                <example src="EGRAM" no="46">
                    <text>Both the 5 and 3 splice site mutations (1060 + 2t--&gt;c and 678-7g--&gt;a, respectively), in contrast, has resulted in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
                    <arg n="0">Both the 5 and 3 splice site mutations</arg>
                    <arg n="1">high proportions of mature mRNAs containing introns</arg>
                </example>
                <example src="EGRAM" no="47">
                    <text>Both the 5 and 3 splice site mutations (1060 + 2t--&gt;c and 678-7g--&gt;a, respectively), in contrast, have the ability to result in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
                    <arg n="0">Both the 5 and 3 splice site mutations</arg>
                    <arg n="1">high proportions of mature mRNAs containing introns</arg>
                </example>
                <example src="EGRAM" no="48">
                    <text>Both the 5 and 3 splice site mutations (1060 + 2t--&gt;c and 678-7g--&gt;a, respectively), in contrast, may have resulted in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
                    <arg n="0">Both the 5 and 3 splice site mutations</arg>
                    <arg n="1">high proportions of mature mRNAs containing introns</arg>
                </example>
                <example src="EGRAM" no="49">
                    <text>Both the 5 and 3 splice site mutations (1060 + 2t--&gt;c and 678-7g--&gt;a, respectively), in contrast, result in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
                    <arg n="0">Both the 5 and 3 splice site mutations</arg>
                    <arg n="1">high proportions of mature mRNAs containing introns</arg>
                </example>
                <example src="EGRAM" no="50">
                    <text>Both the 5 and 3 splice site mutations (1060 + 2t--&gt;c and 678-7g--&gt;a, respectively), in contrast, resulted in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
                    <arg n="0">Both the 5 and 3 splice site mutations</arg>
                    <arg n="1">high proportions of mature mRNAs containing introns</arg>
                </example>
                <example src="EGRAM" no="51">
                    <text>Both the 5 and 3 splice site mutations (1060 + 2t--&gt;c and 678-7g--&gt;a, respectively), in contrast, will result in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
                    <arg n="0">Both the 5 and 3 splice site mutations</arg>
                    <arg n="1">high proportions of mature mRNAs containing introns</arg>
                </example>
                <example src="EGRAM" no="52">
                    <text>Complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (CJD) revealed a new mutation at codon 210 being able to result in the substitution of isoleucine for valine.</text>
                    <arg n="0">a new mutation at codon 210</arg>
                    <arg n="1">the substitution of isoleucine for valine</arg>
                </example>
                <example src="EGRAM" no="53">
                    <text>Complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (CJD) revealed a new mutation at codon 210 being observed to result in the substitution of isoleucine for valine.</text>
                    <arg n="0">a new mutation at codon 210</arg>
                    <arg n="1">the substitution of isoleucine for valine</arg>
                </example>
                <example src="EGRAM" no="54">
                    <text>Complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (CJD) revealed a new mutation at codon 210 having resulted in the substitution of isoleucine for valine.</text>
                    <arg n="0">a new mutation at codon 210</arg>
                    <arg n="1">the substitution of isoleucine for valine</arg>
                </example>
                <example src="EGRAM" no="55">
                    <text>Complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (CJD) revealed a new mutation at codon 210 having the ability to result in the substitution of isoleucine for valine.</text>
                    <arg n="0">a new mutation at codon 210</arg>
                    <arg n="1">the substitution of isoleucine for valine</arg>
                </example>
                <example src="EGRAM" no="56">
                    <text>Complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (CJD) revealed a new mutation at codon 210 that has the ability to result in the substitution of isoleucine for valine.</text>
                    <arg n="0">a new mutation at codon 210</arg>
                    <arg n="1">the substitution of isoleucine for valine</arg>
                </example>
                <example src="EGRAM" no="57">
                    <text>Complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (CJD) revealed a new mutation at codon 210 that is able to result in the substitution of isoleucine for valine.</text>
                    <arg n="0">a new mutation at codon 210</arg>
                    <arg n="1">the substitution of isoleucine for valine</arg>
                </example>
                <example src="EGRAM" no="58">
                    <text>Complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (CJD) revealed a new mutation at codon 210 that is observed to result in the substitution of isoleucine for valine.</text>
                    <arg n="0">a new mutation at codon 210</arg>
                    <arg n="1">the substitution of isoleucine for valine</arg>
                </example>
                <example src="EGRAM" no="59">
                    <text>Complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (CJD) revealed a new mutation at codon 210 that may have resulted in the substitution of isoleucine for valine.</text>
                    <arg n="0">a new mutation at codon 210</arg>
                    <arg n="1">the substitution of isoleucine for valine</arg>
                </example>
                <example src="EGRAM" no="60">
                    <text>Complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (CJD) revealed a new mutation at codon 210 that resulted in the substitution of isoleucine for valine.</text>
                    <arg n="0">a new mutation at codon 210</arg>
                    <arg n="1">the substitution of isoleucine for valine</arg>
                </example>
                <example src="EGRAM" no="61">
                    <text>Complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (CJD) revealed a new mutation at codon 210 which can result in the substitution of isoleucine for valine.</text>
                    <arg n="0">a new mutation at codon 210</arg>
                    <arg n="1">the substitution of isoleucine for valine</arg>
                </example>
                <example src="EGRAM" no="62">
                    <text>Complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (CJD) revealed a new mutation at codon 210 which has resulted in the substitution of isoleucine for valine.</text>
                    <arg n="0">a new mutation at codon 210</arg>
                    <arg n="1">the substitution of isoleucine for valine</arg>
                </example>
                <example src="EGRAM" no="63">
                    <text>Complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (CJD) revealed a new mutation at codon 210 which results in the substitution of isoleucine for valine.</text>
                    <arg n="0">a new mutation at codon 210</arg>
                    <arg n="1">the substitution of isoleucine for valine</arg>
                </example>
                <example src="EGRAM" no="64">
                    <text>Complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (CJD) revealed a new mutation at codon 210 which will result in the substitution of isoleucine for valine.</text>
                    <arg n="0">a new mutation at codon 210</arg>
                    <arg n="1">the substitution of isoleucine for valine</arg>
                </example>
                <example src="EGRAM" no="65">
                    <text>Decreased EGL-15 signaling that can result in a scrawny body morphology phenotype(Kokel et al., 1998) is conferred by a partial lf egl-15 mutation,.</text>
                    <arg n="0">Decreased EGL-15 signaling</arg>
                    <arg n="1">a scrawny body morphology phenotype</arg>
                </example>
                <example src="EGRAM" no="66">
                    <text>Decreased EGL-15 signaling that has resulted in a scrawny body morphology phenotype(Kokel et al., 1998) is conferred by a partial lf egl-15 mutation,.</text>
                    <arg n="0">Decreased EGL-15 signaling</arg>
                    <arg n="1">a scrawny body morphology phenotype</arg>
                </example>
                <example src="EGRAM" no="67">
                    <text>Decreased EGL-15 signaling that has the ability to result in a scrawny body morphology phenotype(Kokel et al., 1998) is conferred by a partial lf egl-15 mutation,.</text>
                    <arg n="0">Decreased EGL-15 signaling</arg>
                    <arg n="1">a scrawny body morphology phenotype</arg>
                </example>
                <example src="EGRAM" no="68">
                    <text>Decreased EGL-15 signaling that is able to result in a scrawny body morphology phenotype(Kokel et al., 1998) is conferred by a partial lf egl-15 mutation,.</text>
                    <arg n="0">Decreased EGL-15 signaling</arg>
                    <arg n="1">a scrawny body morphology phenotype</arg>
                </example>
                <example src="EGRAM" no="69">
                    <text>Decreased EGL-15 signaling that is observed to result in a scrawny body morphology phenotype(Kokel et al., 1998) is conferred by a partial lf egl-15 mutation,.</text>
                    <arg n="0">Decreased EGL-15 signaling</arg>
                    <arg n="1">a scrawny body morphology phenotype</arg>
                </example>
                <example src="EGRAM" no="70">
                    <text>Decreased EGL-15 signaling that may have resulted in a scrawny body morphology phenotype(Kokel et al., 1998) is conferred by a partial lf egl-15 mutation,.</text>
                    <arg n="0">Decreased EGL-15 signaling</arg>
                    <arg n="1">a scrawny body morphology phenotype</arg>
                </example>
                <example src="EGRAM" no="71">
                    <text>Decreased EGL-15 signaling that may result in a scrawny body morphology phenotype(Kokel et al., 1998) is conferred by a partial lf egl-15 mutation,.</text>
                    <arg n="0">Decreased EGL-15 signaling</arg>
                    <arg n="1">a scrawny body morphology phenotype</arg>
                </example>
                <example src="EGRAM" no="72">
                    <text>Decreased EGL-15 signaling that resulted in a scrawny body morphology phenotype(Kokel et al., 1998) is conferred by a partial lf egl-15 mutation,.</text>
                    <arg n="0">Decreased EGL-15 signaling</arg>
                    <arg n="1">a scrawny body morphology phenotype</arg>
                </example>
                <example src="EGRAM" no="73">
                    <text>Decreased EGL-15 signaling that results in a scrawny body morphology phenotype(Kokel et al., 1998) is conferred by a partial lf egl-15 mutation,.</text>
                    <arg n="0">Decreased EGL-15 signaling</arg>
                    <arg n="1">a scrawny body morphology phenotype</arg>
                </example>
                <example src="EGRAM" no="74">
                    <text>Decreased EGL-15 signaling that will result in a scrawny body morphology phenotype(Kokel et al., 1998) is conferred by a partial lf egl-15 mutation,.</text>
                    <arg n="0">Decreased EGL-15 signaling</arg>
                    <arg n="1">a scrawny body morphology phenotype</arg>
                </example>
                <example src="EGRAM" no="75">
                    <text>Decreased EGL-15 signaling, conferred by a partial lf egl-15 mutation, can result in a scrawny body morphology phenotype(Kokel et al., 1998).</text>
                    <arg n="0">Decreased EGL-15 signaling</arg>
                    <arg n="1">a scrawny body morphology phenotype</arg>
                </example>
                <example src="EGRAM" no="76">
                    <text>Decreased EGL-15 signaling, conferred by a partial lf egl-15 mutation, has resulted in a scrawny body morphology phenotype(Kokel et al., 1998).</text>
                    <arg n="0">Decreased EGL-15 signaling</arg>
                    <arg n="1">a scrawny body morphology phenotype</arg>
                </example>
                <example src="EGRAM" no="77">
                    <text>Decreased EGL-15 signaling, conferred by a partial lf egl-15 mutation, has the ability to result in a scrawny body morphology phenotype(Kokel et al., 1998).</text>
                    <arg n="0">Decreased EGL-15 signaling</arg>
                    <arg n="1">a scrawny body morphology phenotype</arg>
                </example>
                <example src="EGRAM" no="78">
                    <text>Decreased EGL-15 signaling, conferred by a partial lf egl-15 mutation, is able to result in a scrawny body morphology phenotype(Kokel et al., 1998).</text>
                    <arg n="0">Decreased EGL-15 signaling</arg>
                    <arg n="1">a scrawny body morphology phenotype</arg>
                </example>
                <example src="EGRAM" no="79">
                    <text>Decreased EGL-15 signaling, conferred by a partial lf egl-15 mutation, is observed to result in a scrawny body morphology phenotype(Kokel et al., 1998).</text>
                    <arg n="0">Decreased EGL-15 signaling</arg>
                    <arg n="1">a scrawny body morphology phenotype</arg>
                </example>
                <example src="EGRAM" no="80">
                    <text>Decreased EGL-15 signaling, conferred by a partial lf egl-15 mutation, may have resulted in a scrawny body morphology phenotype(Kokel et al., 1998).</text>
                    <arg n="0">Decreased EGL-15 signaling</arg>
                    <arg n="1">a scrawny body morphology phenotype</arg>
                </example>
                <example src="EGRAM" no="81">
                    <text>Decreased EGL-15 signaling, conferred by a partial lf egl-15 mutation, may result in a scrawny body morphology phenotype(Kokel et al., 1998).</text>
                    <arg n="0">Decreased EGL-15 signaling</arg>
                    <arg n="1">a scrawny body morphology phenotype</arg>
                </example>
                <example src="EGRAM" no="82">
                    <text>Decreased EGL-15 signaling, conferred by a partial lf egl-15 mutation, resulted in a scrawny body morphology phenotype(Kokel et al., 1998).</text>
                    <arg n="0">Decreased EGL-15 signaling</arg>
                    <arg n="1">a scrawny body morphology phenotype</arg>
                </example>
                <example src="EGRAM" no="83">
                    <text>Exon 13 skipping in s1031 animals can finally result in a 543 bp product.</text>
                    <arg n="0">Exon 13 skipping in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="EGRAM" no="84">
                    <text>Exon 13 skipping in s1031 animals can result in a 543 bp product.</text>
                    <arg n="0">Exon 13 skipping in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="EGRAM" no="85">
                    <text>Exon 13 skipping in s1031 animals finally resulted in a 543 bp product.</text>
                    <arg n="0">Exon 13 skipping in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="EGRAM" no="86">
                    <text>Exon 13 skipping in s1031 animals has finally resulted in a 543 bp product.</text>
                    <arg n="0">Exon 13 skipping in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="EGRAM" no="87">
                    <text>Exon 13 skipping in s1031 animals has resulted in a 543 bp product.</text>
                    <arg n="0">Exon 13 skipping in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="EGRAM" no="88">
                    <text>Exon 13 skipping in s1031 animals has the ability to finally result in a 543 bp product.</text>
                    <arg n="0">Exon 13 skipping in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="EGRAM" no="89">
                    <text>Exon 13 skipping in s1031 animals has the ability to result in a 543 bp product.</text>
                    <arg n="0">Exon 13 skipping in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="EGRAM" no="90">
                    <text>Exon 13 skipping in s1031 animals has the probability of resulting in a 543 bp product.</text>
                    <arg n="0">Exon 13 skipping in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="EGRAM" no="91">
                    <text>Exon 13 skipping in s1031 animals is able to finally result in a 543 bp product.</text>
                    <arg n="0">Exon 13 skipping in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="EGRAM" no="92">
                    <text>Exon 13 skipping in s1031 animals is able to result in a 543 bp product.</text>
                    <arg n="0">Exon 13 skipping in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="EGRAM" no="93">
                    <text>Exon 13 skipping in s1031 animals is shown to finally result in a 543 bp product.</text>
                    <arg n="0">Exon 13 skipping in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="EGRAM" no="94">
                    <text>Exon 13 skipping in s1031 animals is shown to result in a 543 bp product.</text>
                    <arg n="0">Exon 13 skipping in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="EGRAM" no="95">
                    <text>Exon 13 skipping in s1031 animals may have finally resulted in a 543 bp product.</text>
                    <arg n="0">Exon 13 skipping in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="EGRAM" no="96">
                    <text>Exon 13 skipping in s1031 animals may have resulted in a 543 bp product.</text>
                    <arg n="0">Exon 13 skipping in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="EGRAM" no="97">
                    <text>Exon 13 skipping in s1031 animals resulted in a 543 bp product.</text>
                    <arg n="0">Exon 13 skipping in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="EGRAM" no="98">
                    <text>Exon 13 skipping in s1031 animals will finally result in a 543 bp product.</text>
                    <arg n="0">Exon 13 skipping in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="EGRAM" no="99">
                    <text>Exon 13 skipping in s1031 animals will result in a 543 bp product.</text>
                    <arg n="0">Exon 13 skipping in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="EGRAM" no="100">
                    <text>Expression of isoform II cDNA in COS7 cells are able to finally result in a marked increase in PAF acetylhydrolase activity.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in PAF acetylhydrolase activity</arg>
                </example>
                <example src="EGRAM" no="101">
                    <text>Expression of isoform II cDNA in COS7 cells are able to result in a marked increase in PAF acetylhydrolase activity.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in PAF acetylhydrolase activity</arg>
                </example>
                <example src="EGRAM" no="102">
                    <text>Expression of isoform II cDNA in COS7 cells are observed to finally result in a marked increase in PAF acetylhydrolase activity.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in PAF acetylhydrolase activity</arg>
                </example>
                <example src="EGRAM" no="103">
                    <text>Expression of isoform II cDNA in COS7 cells are observed to result in a marked increase in PAF acetylhydrolase activity.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in PAF acetylhydrolase activity</arg>
                </example>
                <example src="EGRAM" no="104">
                    <text>Expression of isoform II cDNA in COS7 cells can finally result in a marked increase in PAF acetylhydrolase activity</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in PAF acetylhydrolase activity</arg>
                </example>
                <example src="EGRAM" no="105">
                    <text>Expression of isoform II cDNA in COS7 cells can result in a marked increase in PAF acetylhydrolase activity</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in PAF acetylhydrolase activity</arg>
                </example>
                <example src="EGRAM" no="106">
                    <text>Expression of isoform II cDNA in COS7 cells finally result in a marked increase in PAF acetylhydrolase activity.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in PAF acetylhydrolase activity</arg>
                </example>
                <example src="EGRAM" no="107">
                    <text>Expression of isoform II cDNA in COS7 cells has finally resulted in a marked increase in PAF acetylhydrolase activity.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in PAF acetylhydrolase activity</arg>
                </example>
                <example src="EGRAM" no="108">
                    <text>Expression of isoform II cDNA in COS7 cells has resulted in a marked increase in PAF acetylhydrolase activity.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in PAF acetylhydrolase activity</arg>
                </example>
                <example src="EGRAM" no="109">
                    <text>Expression of isoform II cDNA in COS7 cells have the ability to finally result in a marked increase in PAF acetylhydrolase activity.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in PAF acetylhydrolase activity</arg>
                </example>
                <example src="EGRAM" no="110">
                    <text>Expression of isoform II cDNA in COS7 cells have the ability to result in a marked increase in PAF acetylhydrolase activity.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in PAF acetylhydrolase activity</arg>
                </example>
                <example src="EGRAM" no="111">
                    <text>Expression of isoform II cDNA in COS7 cells may finally result in a marked increase in PAF acetylhydrolase activity.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in PAF acetylhydrolase activity</arg>
                </example>
                <example src="EGRAM" no="112">
                    <text>Expression of isoform II cDNA in COS7 cells may have finally resulted in a marked increase in PAF acetylhydrolase activity.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in PAF acetylhydrolase activity</arg>
                </example>
                <example src="EGRAM" no="113">
                    <text>Expression of isoform II cDNA in COS7 cells may have resulted in a marked increase in PAF acetylhydrolase activity.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in PAF acetylhydrolase activity</arg>
                </example>
                <example src="EGRAM" no="114">
                    <text>Expression of isoform II cDNA in COS7 cells may result in a marked increase in PAF acetylhydrolase activity.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in PAF acetylhydrolase activity</arg>
                </example>
                <example src="EGRAM" no="115">
                    <text>Expression of isoform II cDNA in COS7 cells result in a marked increase in PAF acetylhydrolase activity.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in PAF acetylhydrolase activity</arg>
                </example>
                <example src="EGRAM" no="116">
                    <text>Expression of isoform II cDNA in COS7 cells will finally result in a marked increase in PAF acetylhydrolase activity.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in PAF acetylhydrolase activity</arg>
                </example>
                <example src="EGRAM" no="117">
                    <text>Expression of isoform II cDNA in COS7 cells will result in a marked increase in PAF acetylhydrolase activity.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in PAF acetylhydrolase activity</arg>
                </example>
                <example src="EGRAM" no="118">
                    <text>Fluctuation in the ras-dependent signaling can result in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                    <arg n="0">fluctuation in the ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
                </example>
                <example src="EGRAM" no="119">
                    <text>Fluctuation in the ras-dependent signaling has resulted in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                    <arg n="0">fluctuation in the ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
                </example>
                <example src="EGRAM" no="120">
                    <text>Fluctuation in the ras-dependent signaling has the ability to result in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                    <arg n="0">fluctuation in the ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
                </example>
                <example src="EGRAM" no="121">
                    <text>Fluctuation in the ras-dependent signaling has the probability of resulting in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                    <arg n="0">fluctuation in the ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
                </example>
                <example src="EGRAM" no="122">
                    <text>Fluctuation in the ras-dependent signaling is able to result in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                    <arg n="0">fluctuation in the ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
                </example>
                <example src="EGRAM" no="123">
                    <text>Fluctuation in the ras-dependent signaling is observed to result in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                    <arg n="0">fluctuation in the ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
                </example>
                <example src="EGRAM" no="124">
                    <text>Fluctuation in the ras-dependent signaling may have resulted in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                    <arg n="0">fluctuation in the ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
                </example>
                <example src="EGRAM" no="125">
                    <text>Fluctuation in the ras-dependent signaling may result in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                    <arg n="0">fluctuation in the ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
                </example>
                <example src="EGRAM" no="126">
                    <text>Fluctuation in the ras-dependent signaling resulted in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                    <arg n="0">fluctuation in the ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
                </example>
                <example src="EGRAM" no="127">
                    <text>Fluctuation in the ras-dependent signaling results in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                    <arg n="0">fluctuation in the ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
                </example>
                <example src="EGRAM" no="128">
                    <text>Fluctuation in the ras-dependent signaling will result in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                    <arg n="0">fluctuation in the ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
                </example>
                <example src="EGRAM" no="129">
                    <text>Fluctuation in the ras-dependent signaling, as we predicted, can result in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                    <arg n="0">fluctuation in the ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
                </example>
                <example src="EGRAM" no="130">
                    <text>Fluctuation in the ras-dependent signaling, as we predicted, has resulted in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                    <arg n="0">fluctuation in the ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
                </example>
                <example src="EGRAM" no="131">
                    <text>Fluctuation in the ras-dependent signaling, as we predicted, has the ability to result in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                    <arg n="0">fluctuation in the ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
                </example>
                <example src="EGRAM" no="132">
                    <text>Fluctuation in the ras-dependent signaling, as we predicted, has the probability of resulting in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                    <arg n="0">fluctuation in the ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
                </example>
                <example src="EGRAM" no="133">
                    <text>Fluctuation in the ras-dependent signaling, as we predicted, is able to result in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                    <arg n="0">fluctuation in the ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
                </example>
                <example src="EGRAM" no="134">
                    <text>Fluctuation in the ras-dependent signaling, as we predicted, is observed to result in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                    <arg n="0">fluctuation in the ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
                </example>
                <example src="EGRAM" no="135">
                    <text>Fluctuation in the ras-dependent signaling, as we predicted, may have resulted in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                    <arg n="0">fluctuation in the ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
                </example>
                <example src="EGRAM" no="136">
                    <text>Fluctuation in the ras-dependent signaling, as we predicted, may result in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                    <arg n="0">fluctuation in the ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
                </example>
                <example src="EGRAM" no="137">
                    <text>Fluctuation in the ras-dependent signaling, as we predicted, resulted in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                    <arg n="0">fluctuation in the ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
                </example>
                <example src="EGRAM" no="138">
                    <text>Fluctuation in the ras-dependent signaling, as we predicted, results in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                    <arg n="0">fluctuation in the ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
                </example>
                <example src="EGRAM" no="139">
                    <text>Fluctuation in the ras-dependent signaling, as we predicted, will result in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                    <arg n="0">fluctuation in the ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
                </example>
                <example src="EGRAM" no="140">
                    <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains being able to completely result in a super-repeat.</text>
                    <arg n="0">various alternate subdomains</arg>
                    <arg n="1">a super-repeat</arg>
                </example>
                <example src="EGRAM" no="141">
                    <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains being able to result in a super-repeat.</text>
                    <arg n="0">various alternate subdomains</arg>
                    <arg n="1">a super-repeat</arg>
                </example>
                <example src="EGRAM" no="142">
                    <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains being observed to completely result in a super-repeat.</text>
                    <arg n="0">various alternate subdomains</arg>
                    <arg n="1">a super-repeat</arg>
                </example>
                <example src="EGRAM" no="143">
                    <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains being observed to result in a super-repeat.</text>
                    <arg n="0">various alternate subdomains</arg>
                    <arg n="1">a super-repeat</arg>
                </example>
                <example src="EGRAM" no="144">
                    <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains having completely resulted in a super-repeat.</text>
                    <arg n="0">various alternate subdomains</arg>
                    <arg n="1">a super-repeat</arg>
                </example>
                <example src="EGRAM" no="145">
                    <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains having resulted in a super-repeat.</text>
                    <arg n="0">various alternate subdomains</arg>
                    <arg n="1">a super-repeat</arg>
                </example>
                <example src="EGRAM" no="146">
                    <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains having the ability to completely result in a super-repeat.</text>
                    <arg n="0">various alternate subdomains</arg>
                    <arg n="1">a super-repeat</arg>
                </example>
                <example src="EGRAM" no="147">
                    <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains having the ability to result in a super-repeat.</text>
                    <arg n="0">various alternate subdomains</arg>
                    <arg n="1">a super-repeat</arg>
                </example>
                <example src="EGRAM" no="148">
                    <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which are able to completely result in a super-repeat.</text>
                    <arg n="0">various alternate subdomains</arg>
                    <arg n="1">a super-repeat</arg>
                </example>
                <example src="EGRAM" no="149">
                    <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which are able to result in a super-repeat.</text>
                    <arg n="0">various alternate subdomains</arg>
                    <arg n="1">a super-repeat</arg>
                </example>
                <example src="EGRAM" no="150">
                    <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which are observed to completely result in a super-repeat.</text>
                    <arg n="0">various alternate subdomains</arg>
                    <arg n="1">a super-repeat</arg>
                </example>
                <example src="EGRAM" no="151">
                    <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which are observed to result in a super-repeat.</text>
                    <arg n="0">various alternate subdomains</arg>
                    <arg n="1">a super-repeat</arg>
                </example>
                <example src="EGRAM" no="152">
                    <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which can completely result in a super-repeat.</text>
                    <arg n="0">various alternate subdomains</arg>
                    <arg n="1">a super-repeat</arg>
                </example>
                <example src="EGRAM" no="153">
                    <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which can result in a super-repeat.</text>
                    <arg n="0">various alternate subdomains</arg>
                    <arg n="1">a super-repeat</arg>
                </example>
                <example src="EGRAM" no="154">
                    <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which completely result in a super-repeat.</text>
                    <arg n="0">various alternate subdomains</arg>
                    <arg n="1">a super-repeat</arg>
                </example>
                <example src="EGRAM" no="155">
                    <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which completely resulted in a super-repeat.</text>
                    <arg n="0">various alternate subdomains</arg>
                    <arg n="1">a super-repeat</arg>
                </example>
                <example src="EGRAM" no="156">
                    <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which have completely resulted in a super-repeat.</text>
                    <arg n="0">various alternate subdomains</arg>
                    <arg n="1">a super-repeat</arg>
                </example>
                <example src="EGRAM" no="157">
                    <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which have resulted in a super-repeat.</text>
                    <arg n="0">various alternate subdomains</arg>
                    <arg n="1">a super-repeat</arg>
                </example>
                <example src="EGRAM" no="158">
                    <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which have the ability to completely result in a super-repeat.</text>
                    <arg n="0">various alternate subdomains</arg>
                    <arg n="1">a super-repeat</arg>
                </example>
                <example src="EGRAM" no="159">
                    <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which have the ability to result in a super-repeat.</text>
                    <arg n="0">various alternate subdomains</arg>
                    <arg n="1">a super-repeat</arg>
                </example>
                <example src="EGRAM" no="160">
                    <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which may have completely resulted in a super-repeat.</text>
                    <arg n="0">various alternate subdomains</arg>
                    <arg n="1">a super-repeat</arg>
                </example>
                <example src="EGRAM" no="161">
                    <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which may have resulted in a super-repeat.</text>
                    <arg n="0">various alternate subdomains</arg>
                    <arg n="1">a super-repeat</arg>
                </example>
                <example src="EGRAM" no="162">
                    <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which result in a super-repeat.</text>
                    <arg n="0">various alternate subdomains</arg>
                    <arg n="1">a super-repeat</arg>
                </example>
                <example src="EGRAM" no="163">
                    <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which resulted in a super-repeat.</text>
                    <arg n="0">various alternate subdomains</arg>
                    <arg n="1">a super-repeat</arg>
                </example>
                <example src="EGRAM" no="164">
                    <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which will completely result in a super-repeat.</text>
                    <arg n="0">various alternate subdomains</arg>
                    <arg n="1">a super-repeat</arg>
                </example>
                <example src="EGRAM" no="165">
                    <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which will result in a super-repeat.</text>
                    <arg n="0">various alternate subdomains</arg>
                    <arg n="1">a super-repeat</arg>
                </example>
                <example src="EGRAM" no="166">
                    <text>Induction of a mutation in the lacI gene can result in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                    <arg n="0">Induction of a mutation in the lacI gene</arg>
                    <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="EGRAM" no="167">
                    <text>Induction of a mutation in the lacI gene could have resulted in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                    <arg n="0">Induction of a mutation in the lacI gene</arg>
                    <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="EGRAM" no="168">
                    <text>Induction of a mutation in the lacI gene has resulted in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                    <arg n="0">Induction of a mutation in the lacI gene</arg>
                    <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="EGRAM" no="169">
                    <text>Induction of a mutation in the lacI gene has the ability to result in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                    <arg n="0">Induction of a mutation in the lacI gene</arg>
                    <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="EGRAM" no="170">
                    <text>Induction of a mutation in the lacI gene is able to result in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                    <arg n="0">Induction of a mutation in the lacI gene</arg>
                    <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="EGRAM" no="171">
                    <text>Induction of a mutation in the lacI gene is observed to result in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                    <arg n="0">Induction of a mutation in the lacI gene</arg>
                    <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="EGRAM" no="172">
                    <text>Induction of a mutation in the lacI gene may have resulted in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                    <arg n="0">Induction of a mutation in the lacI gene</arg>
                    <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="EGRAM" no="173">
                    <text>Induction of a mutation in the lacI gene may result in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                    <arg n="0">Induction of a mutation in the lacI gene</arg>
                    <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="EGRAM" no="174">
                    <text>Induction of a mutation in the lacI gene resulted in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                    <arg n="0">Induction of a mutation in the lacI gene</arg>
                    <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="EGRAM" no="175">
                    <text>Induction of a mutation in the lacI gene results in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                    <arg n="0">Induction of a mutation in the lacI gene</arg>
                    <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="EGRAM" no="176">
                    <text>Induction of a mutation in the lacI gene will result in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                    <arg n="0">Induction of a mutation in the lacI gene</arg>
                    <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="EGRAM" no="177">
                    <text>Induction of a mutation in the lacI gene, as our study revealed, can result in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                    <arg n="0">Induction of a mutation in the lacI gene</arg>
                    <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="EGRAM" no="178">
                    <text>Induction of a mutation in the lacI gene, as our study revealed, could have resulted in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                    <arg n="0">Induction of a mutation in the lacI gene</arg>
                    <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="EGRAM" no="179">
                    <text>Induction of a mutation in the lacI gene, as our study revealed, has resulted in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                    <arg n="0">Induction of a mutation in the lacI gene</arg>
                    <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="EGRAM" no="180">
                    <text>Induction of a mutation in the lacI gene, as our study revealed, has the ability to result in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                    <arg n="0">Induction of a mutation in the lacI gene</arg>
                    <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="EGRAM" no="181">
                    <text>Induction of a mutation in the lacI gene, as our study revealed, is able to result in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                    <arg n="0">Induction of a mutation in the lacI gene</arg>
                    <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="EGRAM" no="182">
                    <text>Induction of a mutation in the lacI gene, as our study revealed, is observed to result in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                    <arg n="0">Induction of a mutation in the lacI gene</arg>
                    <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="EGRAM" no="183">
                    <text>Induction of a mutation in the lacI gene, as our study revealed, may have resulted in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                    <arg n="0">Induction of a mutation in the lacI gene</arg>
                    <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="EGRAM" no="184">
                    <text>Induction of a mutation in the lacI gene, as our study revealed, may result in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                    <arg n="0">Induction of a mutation in the lacI gene</arg>
                    <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="EGRAM" no="185">
                    <text>Induction of a mutation in the lacI gene, as our study revealed, resulted in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                    <arg n="0">Induction of a mutation in the lacI gene</arg>
                    <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="EGRAM" no="186">
                    <text>Induction of a mutation in the lacI gene, as our study revealed, results in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                    <arg n="0">Induction of a mutation in the lacI gene</arg>
                    <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="EGRAM" no="187">
                    <text>Induction of a mutation in the lacI gene, as our study revealed, will result in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                    <arg n="0">Induction of a mutation in the lacI gene</arg>
                    <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="EGRAM" no="188">
                    <text>Mutations being able to result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="0">simultaneous derepression of both genes</arg>
                </example>
                <example src="EGRAM" no="189">
                    <text>Mutations being observed to result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="0">simultaneous derepression of both genes</arg>
                </example>
                <example src="EGRAM" no="190">
                    <text>Mutations having resulted in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="0">simultaneous derepression of both genes</arg>
                </example>
                <example src="EGRAM" no="191">
                    <text>Mutations having the ability to result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="0">simultaneous derepression of both genes</arg>
                </example>
                <example src="EGRAM" no="192">
                    <text>Mutations resulting in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="0">simultaneous derepression of both genes</arg>
                </example>
                <example src="EGRAM" no="193">
                    <text>Mutations that are able to result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="0">simultaneous derepression of both genes</arg>
                </example>
                <example src="EGRAM" no="194">
                    <text>Mutations that are observed to result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="0">simultaneous derepression of both genes</arg>
                </example>
                <example src="EGRAM" no="195">
                    <text>Mutations that can result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="0">simultaneous derepression of both genes</arg>
                </example>
                <example src="EGRAM" no="196">
                    <text>Mutations that have resulted in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="0">simultaneous derepression of both genes</arg>
                </example>
                <example src="EGRAM" no="197">
                    <text>Mutations that have the ability to result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="0">simultaneous derepression of both genes</arg>
                </example>
                <example src="EGRAM" no="198">
                    <text>Mutations that may have resulted in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="0">simultaneous derepression of both genes</arg>
                </example>
                <example src="EGRAM" no="199">
                    <text>Mutations that may result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="0">simultaneous derepression of both genes</arg>
                </example>
                <example src="EGRAM" no="200">
                    <text>Mutations that result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="0">simultaneous derepression of both genes</arg>
                </example>
                <example src="EGRAM" no="201">
                    <text>Mutations that resulted in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="0">simultaneous derepression of both genes</arg>
                </example>
                <example src="EGRAM" no="202">
                    <text>Mutations that will result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="0">simultaneous derepression of both genes</arg>
                </example>
                <example src="EGRAM" no="203">
                    <text>Mutations which prevent repressor binding to either site or alter the phasing of the binding sites are able to result in simultaneous derepression of both genes.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="0">simultaneous derepression of both genes</arg>
                </example>
                <example src="EGRAM" no="204">
                    <text>Mutations which prevent repressor binding to either site or alter the phasing of the binding sites are observed to result in simultaneous derepression of both genes.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="0">simultaneous derepression of both genes</arg>
                </example>
                <example src="EGRAM" no="205">
                    <text>Mutations which prevent repressor binding to either site or alter the phasing of the binding sites can result in simultaneous derepression of both genes.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="0">simultaneous derepression of both genes</arg>
                </example>
                <example src="EGRAM" no="206">
                    <text>Mutations which prevent repressor binding to either site or alter the phasing of the binding sites have resulted in simultaneous derepression of both genes.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="0">simultaneous derepression of both genes</arg>
                </example>
                <example src="EGRAM" no="207">
                    <text>Mutations which prevent repressor binding to either site or alter the phasing of the binding sites have the ability to result in simultaneous derepression of both genes.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="0">simultaneous derepression of both genes</arg>
                </example>
                <example src="EGRAM" no="208">
                    <text>Mutations which prevent repressor binding to either site or alter the phasing of the binding sites may have resulted in simultaneous derepression of both genes.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="0">simultaneous derepression of both genes</arg>
                </example>
                <example src="EGRAM" no="209">
                    <text>Mutations which prevent repressor binding to either site or alter the phasing of the binding sites may result in simultaneous derepression of both genes.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="0">simultaneous derepression of both genes</arg>
                </example>
                <example src="EGRAM" no="210">
                    <text>Mutations which prevent repressor binding to either site or alter the phasing of the binding sites result in simultaneous derepression of both genes.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="0">simultaneous derepression of both genes</arg>
                </example>
                <example src="EGRAM" no="211">
                    <text>Mutations which prevent repressor binding to either site or alter the phasing of the binding sites resulted in simultaneous derepression of both genes.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="0">simultaneous derepression of both genes</arg>
                </example>
                <example src="EGRAM" no="212">
                    <text>Mutations which prevent repressor binding to either site or alter the phasing of the binding sites will result in simultaneous derepression of both genes.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="0">simultaneous derepression of both genes</arg>
                </example>
                <example src="EGRAM" no="213">
                    <text>One variant can probably result from failure to use the normal splice donor site of intron 12.</text>
                    <arg n="0">failure to use the normal splice donor site of intron 12</arg>
                    <arg n="1">One variant</arg>
                </example>
                <example src="EGRAM" no="214">
                    <text>One variant can result from failure to use the normal splice donor site of intron 12.</text>
                    <arg n="0">failure to use the normal splice donor site of intron 12</arg>
                    <arg n="1">One variant</arg>
                </example>
                <example src="EGRAM" no="215">
                    <text>One variant has been found to probably result from failure to use the normal splice donor site of intron 12.</text>
                    <arg n="0">failure to use the normal splice donor site of intron 12</arg>
                    <arg n="1">One variant</arg>
                </example>
                <example src="EGRAM" no="216">
                    <text>One variant has been found to result from failure to use the normal splice donor site of intron 12.</text>
                    <arg n="0">failure to use the normal splice donor site of intron 12</arg>
                    <arg n="1">One variant</arg>
                </example>
                <example src="EGRAM" no="217">
                    <text>One variant has probably resulted from failure to use the normal splice donor site of intron 12.</text>
                    <arg n="0">failure to use the normal splice donor site of intron 12</arg>
                    <arg n="1">One variant</arg>
                </example>
                <example src="EGRAM" no="218">
                    <text>One variant has resulted from failure to use the normal splice donor site of intron 12.</text>
                    <arg n="0">failure to use the normal splice donor site of intron 12</arg>
                    <arg n="1">One variant</arg>
                </example>
                <example src="EGRAM" no="219">
                    <text>One variant has shown to probably result from failure to use the normal splice donor site of intron 12.</text>
                    <arg n="0">failure to use the normal splice donor site of intron 12</arg>
                    <arg n="1">One variant</arg>
                </example>
                <example src="EGRAM" no="220">
                    <text>One variant has shown to result from failure to use the normal splice donor site of intron 12.</text>
                    <arg n="0">failure to use the normal splice donor site of intron 12</arg>
                    <arg n="1">One variant</arg>
                </example>
                <example src="EGRAM" no="221">
                    <text>One variant has the ability to probably result from failure to use the normal splice donor site of intron 12.</text>
                    <arg n="0">failure to use the normal splice donor site of intron 12</arg>
                    <arg n="1">One variant</arg>
                </example>
                <example src="EGRAM" no="222">
                    <text>One variant has the ability to result from failure to use the normal splice donor site of intron 12.</text>
                    <arg n="0">failure to use the normal splice donor site of intron 12</arg>
                    <arg n="1">One variant</arg>
                </example>
                <example src="EGRAM" no="223">
                    <text>One variant probably resulted from failure to use the normal splice donor site of intron 12.</text>
                    <arg n="0">failure to use the normal splice donor site of intron 12</arg>
                    <arg n="1">One variant</arg>
                </example>
                <example src="EGRAM" no="224">
                    <text>One variant resulted from failure to use the normal splice donor site of intron 12.</text>
                    <arg n="0">failure to use the normal splice donor site of intron 12</arg>
                    <arg n="1">One variant</arg>
                </example>
                <example src="EGRAM" no="225">
                    <text>One variant was able to probably result from failure to use the normal splice donor site of intron 12.</text>
                    <arg n="0">failure to use the normal splice donor site of intron 12</arg>
                    <arg n="1">One variant</arg>
                </example>
                <example src="EGRAM" no="226">
                    <text>One variant was able to result from failure to use the normal splice donor site of intron 12.</text>
                    <arg n="0">failure to use the normal splice donor site of intron 12</arg>
                    <arg n="1">One variant</arg>
                </example>
                <example src="EGRAM" no="227">
                    <text>One variant was observed to probably result from failure to use the normal splice donor site of intron 12.</text>
                    <arg n="0">failure to use the normal splice donor site of intron 12</arg>
                    <arg n="1">One variant</arg>
                </example>
                <example src="EGRAM" no="228">
                    <text>One variant was observed to result from failure to use the normal splice donor site of intron 12.</text>
                    <arg n="0">failure to use the normal splice donor site of intron 12</arg>
                    <arg n="1">One variant</arg>
                </example>
                <example src="EGRAM" no="229">
                    <text>Sequence analysis of the IDHbeta gene indicates that the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins can resulted from alternative splicing of a single transcript.</text>
                    <arg n="0">alternative splicing of a single transcript</arg>
                    <arg n="1">the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins</arg>
                </example>
                <example src="EGRAM" no="230">
                    <text>Sequence analysis of the IDHbeta gene indicates that the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins has been shown to result from alternative splicing of a single transcript.</text>
                    <arg n="0">alternative splicing of a single transcript</arg>
                    <arg n="1">the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins</arg>
                </example>
                <example src="EGRAM" no="231">
                    <text>Sequence analysis of the IDHbeta gene indicates that the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins has resulted from alternative splicing of a single transcript.</text>
                    <arg n="0">alternative splicing of a single transcript</arg>
                    <arg n="1">the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins</arg>
                </example>
                <example src="EGRAM" no="232">
                    <text>Sequence analysis of the IDHbeta gene indicates that the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins has the ability to result from alternative splicing of a single transcript.</text>
                    <arg n="0">alternative splicing of a single transcript</arg>
                    <arg n="1">the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins</arg>
                </example>
                <example src="EGRAM" no="233">
                    <text>Sequence analysis of the IDHbeta gene indicates that the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins is able to result from alternative splicing of a single transcript.</text>
                    <arg n="0">alternative splicing of a single transcript</arg>
                    <arg n="1">the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins</arg>
                </example>
                <example src="EGRAM" no="234">
                    <text>Sequence analysis of the IDHbeta gene indicates that the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins is observed to result from alternative splicing of a single transcript.</text>
                    <arg n="0">alternative splicing of a single transcript</arg>
                    <arg n="1">the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins</arg>
                </example>
                <example src="EGRAM" no="235">
                    <text>Sequence analysis of the IDHbeta gene indicates that the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins may have resulted from alternative splicing of a single transcript.</text>
                    <arg n="0">alternative splicing of a single transcript</arg>
                    <arg n="1">the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins</arg>
                </example>
                <example src="EGRAM" no="236">
                    <text>Sequence analysis of the IDHbeta gene indicates that the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins resulted from alternative splicing of a single transcript.</text>
                    <arg n="0">alternative splicing of a single transcript</arg>
                    <arg n="1">the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins</arg>
                </example>
                <example src="EGRAM" no="237">
                    <text>Sequence analysis of the IDHbeta gene indicates that the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins will result from alternative splicing of a single transcript.</text>
                    <arg n="0">alternative splicing of a single transcript</arg>
                    <arg n="1">the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins</arg>
                </example>
                <example src="EGRAM" no="238">
                    <text>The change may cause the heat instability and affect the net charge of the variant subunit being able to finally result in an electrophoretic LDH-B subunit variant of the fast type.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="239">
                    <text>The change may cause the heat instability and affect the net charge of the variant subunit being able to result in an electrophoretic LDH-B subunit variant of the fast type.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="240">
                    <text>The change may cause the heat instability and affect the net charge of the variant subunit being observed to finally result in an electrophoretic LDH-B subunit variant of the fast type.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="241">
                    <text>The change may cause the heat instability and affect the net charge of the variant subunit being observed to result in an electrophoretic LDH-B subunit variant of the fast type.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="242">
                    <text>The change may cause the heat instability and affect the net charge of the variant subunit being shown to finally result in an electrophoretic LDH-B subunit variant of the fast type.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="243">
                    <text>The change may cause the heat instability and affect the net charge of the variant subunit being shown to result in an electrophoretic LDH-B subunit variant of the fast type.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="244">
                    <text>The change may cause the heat instability and affect the net charge of the variant subunit having finally resulted in an electrophoretic LDH-B subunit variant of the fast type.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="245">
                    <text>The change may cause the heat instability and affect the net charge of the variant subunit having resulted in an electrophoretic LDH-B subunit variant of the fast type.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="246">
                    <text>The change may cause the heat instability and affect the net charge of the variant subunit that has finally resulted in an electrophoretic LDH-B subunit variant of the fast type.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="247">
                    <text>The change may cause the heat instability and affect the net charge of the variant subunit that has resulted in an electrophoretic LDH-B subunit variant of the fast type.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="248">
                    <text>The change may cause the heat instability and affect the net charge of the variant subunit that will finally result in an electrophoretic LDH-B subunit variant of the fast type.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="249">
                    <text>The change may cause the heat instability and affect the net charge of the variant subunit that will result in an electrophoretic LDH-B subunit variant of the fast type.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="250">
                    <text>The change may cause the heat instability and affect the net charge of the variant subunit which can finally result in an electrophoretic LDH-B subunit variant of the fast type.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="251">
                    <text>The change may cause the heat instability and affect the net charge of the variant subunit which can result in an electrophoretic LDH-B subunit variant of the fast type.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="252">
                    <text>The change may cause the heat instability and affect the net charge of the variant subunit which finally resulted in an electrophoretic LDH-B subunit variant of the fast type.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="253">
                    <text>The change may cause the heat instability and affect the net charge of the variant subunit which finally results in an electrophoretic LDH-B subunit variant of the fast type.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="254">
                    <text>The change may cause the heat instability and affect the net charge of the variant subunit which has been shown to finally result in an electrophoretic LDH-B subunit variant of the fast type.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="255">
                    <text>The change may cause the heat instability and affect the net charge of the variant subunit which has been shown to result in an electrophoretic LDH-B subunit variant of the fast type.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="256">
                    <text>The change may cause the heat instability and affect the net charge of the variant subunit which is able to finally result in an electrophoretic LDH-B subunit variant of the fast type.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="257">
                    <text>The change may cause the heat instability and affect the net charge of the variant subunit which is able to result in an electrophoretic LDH-B subunit variant of the fast type.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="258">
                    <text>The change may cause the heat instability and affect the net charge of the variant subunit which is observed to finally result in an electrophoretic LDH-B subunit variant of the fast type.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="259">
                    <text>The change may cause the heat instability and affect the net charge of the variant subunit which is observed to result in an electrophoretic LDH-B subunit variant of the fast type.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="260">
                    <text>The change may cause the heat instability and affect the net charge of the variant subunit which may have finally resulted in an electrophoretic LDH-B subunit variant of the fast type.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="261">
                    <text>The change may cause the heat instability and affect the net charge of the variant subunit which may have resulted in an electrophoretic LDH-B subunit variant of the fast type.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="262">
                    <text>The change may cause the heat instability and affect the net charge of the variant subunit which resulted in an electrophoretic LDH-B subunit variant of the fast type.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="263">
                    <text>The change may cause the heat instability and affect the net charge of the variant subunit which results in an electrophoretic LDH-B subunit variant of the fast type.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="264">
                    <text>The research shows the existence of isoforms of NF-YA resulting from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="EGRAM" no="265">
                    <text>The research shows the existence of isoforms of NF-YA that results from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="EGRAM" no="266">
                    <text>The research shows the existence of isoforms of NF-YA which resulted from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="EGRAM" no="267">
                    <text>These observations show that repression has been the result of co-operative binding of the repressor to its two sites, resulting in the formation of a loop of DNA.</text>
                    <arg n="0">co-operative binding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="EGRAM" no="268">
                    <text>These observations show that repression is believed to be the result of co-operative binding of the repressor to its two sites, resulting in the formation of a loop of DNA.</text>
                    <arg n="0">co-operative binding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="EGRAM" no="269">
                    <text>These observations show that repression is observed to be the result of co-operative binding of the repressor to its two sites, resulting in the formation of a loop of DNA.</text>
                    <arg n="0">co-operative binding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="EGRAM" no="270">
                    <text>These observations show that repression is the result of co-operative binding of the repressor to its two sites, resulting in the formation of a loop of DNA.</text>
                    <arg n="0">co-operative binding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="EGRAM" no="271">
                    <text>These observations show that repression may be the result of co-operative binding of the repressor to its two sites, resulting in the formation of a loop of DNA.</text>
                    <arg n="0">co-operative binding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="EGRAM" no="272">
                    <text>Two are missense mutations in exon 2 (G339D and R340C), and the other three alterations (a nonsense mutation, a frameshift, and a splicing mutation) are able to result in truncated nonfunctional proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">truncated nonfunctional proteins</arg>
                </example>
                <example src="EGRAM" no="273">
                    <text>Two are missense mutations in exon 2 (G339D and R340C), and the other three alterations (a nonsense mutation, a frameshift, and a splicing mutation) are observed to result in truncated nonfunctional proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">truncated nonfunctional proteins</arg>
                </example>
                <example src="EGRAM" no="274">
                    <text>Two are missense mutations in exon 2 (G339D and R340C), and the other three alterations (a nonsense mutation, a frameshift, and a splicing mutation) can result in truncated nonfunctional proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">truncated nonfunctional proteins</arg>
                </example>
                <example src="EGRAM" no="275">
                    <text>Two are missense mutations in exon 2 (G339D and R340C), and the other three alterations (a nonsense mutation, a frameshift, and a splicing mutation) have been shown to result in truncated nonfunctional proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">truncated nonfunctional proteins</arg>
                </example>
                <example src="EGRAM" no="276">
                    <text>Two are missense mutations in exon 2 (G339D and R340C), and the other three alterations (a nonsense mutation, a frameshift, and a splicing mutation) have resulted in truncated nonfunctional proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">truncated nonfunctional proteins</arg>
                </example>
                <example src="EGRAM" no="277">
                    <text>Two are missense mutations in exon 2 (G339D and R340C), and the other three alterations (a nonsense mutation, a frameshift, and a splicing mutation) have the ability to result in truncated nonfunctional proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">truncated nonfunctional proteins</arg>
                </example>
                <example src="EGRAM" no="278">
                    <text>Two are missense mutations in exon 2 (G339D and R340C), and the other three alterations (a nonsense mutation, a frameshift, and a splicing mutation) have the probability of resulting in truncated nonfunctional proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">truncated nonfunctional proteins</arg>
                </example>
                <example src="EGRAM" no="279">
                    <text>Two are missense mutations in exon 2 (G339D and R340C), and the other three alterations (a nonsense mutation, a frameshift, and a splicing mutation) may have resulted in truncated nonfunctional proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">truncated nonfunctional proteins</arg>
                </example>
                <example src="EGRAM" no="280">
                    <text>Two are missense mutations in exon 2 (G339D and R340C), and the other three alterations (a nonsense mutation, a frameshift, and a splicing mutation) may result in truncated nonfunctional proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">truncated nonfunctional proteins</arg>
                </example>
                <example src="EGRAM" no="281">
                    <text>Two are missense mutations in exon 2 (G339D and R340C), and the other three alterations (a nonsense mutation, a frameshift, and a splicing mutation) result in truncated nonfunctional proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">truncated nonfunctional proteins</arg>
                </example>
                <example src="EGRAM" no="282">
                    <text>Two are missense mutations in exon 2 (G339D and R340C), and the other three alterations (a nonsense mutation, a frameshift, and a splicing mutation) resulted in truncated nonfunctional proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">truncated nonfunctional proteins</arg>
                </example>
                <example src="EGRAM" no="283">
                    <text>Two are missense mutations in exon 2 (G339D and R340C), and the other three alterations (a nonsense mutation, a frameshift, and a splicing mutation) will result in truncated nonfunctional proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">truncated nonfunctional proteins</arg>
                </example>
                <example src="EGRAM" no="284">
                    <text>We also report the existence of isoforms of NF-YA that will result from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="EGRAM" no="285">
                    <text>We also reported the existence of isoforms of NF-YA being able to result from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="EGRAM" no="286">
                    <text>We also reported the existence of isoforms of NF-YA being shown to result from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="EGRAM" no="287">
                    <text>We also reported the existence of isoforms of NF-YA having resulted from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="EGRAM" no="288">
                    <text>We also reported the existence of isoforms of NF-YA having the ability to result from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="EGRAM" no="289">
                    <text>We also reported the existence of isoforms of NF-YA observed to result from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="EGRAM" no="290">
                    <text>We also reported the existence of isoforms of NF-YA that has been shown to result from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="EGRAM" no="291">
                    <text>We also reported the existence of isoforms of NF-YA that has resulted from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="EGRAM" no="292">
                    <text>We also reported the existence of isoforms of NF-YA that has the ability to result from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="EGRAM" no="293">
                    <text>We also reported the existence of isoforms of NF-YA that is able to result from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="EGRAM" no="294">
                    <text>We also reported the existence of isoforms of NF-YA that is observed to result from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="EGRAM" no="295">
                    <text>We also reported the existence of isoforms of NF-YA that may have resulted from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="EGRAM" no="296">
                    <text>We also reported the existence of isoforms of NF-YA that may result from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="EGRAM" no="297">
                    <text>We also reported the existence of isoforms of NF-YA which can result from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="EGRAM" no="298">
                    <text>We show that the negative effect of the cpxA mutation on biofilm formation can result from a decreased transcription of the curlin encoding csgA gene.</text>
                    <arg n="0">a decreased transcription of the curlin encoding csgA gene</arg>
                    <arg n="1">the negative effect of the cpxA mutation</arg>
                </example>
                <example src="EGRAM" no="299">
                    <text>We show that the negative effect of the cpxA mutation on biofilm formation has been shown to result from a decreased transcription of the curlin encoding csgA gene.</text>
                    <arg n="0">a decreased transcription of the curlin encoding csgA gene</arg>
                    <arg n="1">the negative effect of the cpxA mutation</arg>
                </example>
                <example src="EGRAM" no="300">
                    <text>We show that the negative effect of the cpxA mutation on biofilm formation has resulted from a decreased transcription of the curlin encoding csgA gene.</text>
                    <arg n="0">a decreased transcription of the curlin encoding csgA gene</arg>
                    <arg n="1">the negative effect of the cpxA mutation</arg>
                </example>
                <example src="EGRAM" no="301">
                    <text>We show that the negative effect of the cpxA mutation on biofilm formation has the ability to result from a decreased transcription of the curlin encoding csgA gene.</text>
                    <arg n="0">a decreased transcription of the curlin encoding csgA gene</arg>
                    <arg n="1">the negative effect of the cpxA mutation</arg>
                </example>
                <example src="EGRAM" no="302">
                    <text>We show that the negative effect of the cpxA mutation on biofilm formation is able to result from a decreased transcription of the curlin encoding csgA gene.</text>
                    <arg n="0">a decreased transcription of the curlin encoding csgA gene</arg>
                    <arg n="1">the negative effect of the cpxA mutation</arg>
                </example>
                <example src="EGRAM" no="303">
                    <text>We show that the negative effect of the cpxA mutation on biofilm formation is observed to result from a decreased transcription of the curlin encoding csgA gene.</text>
                    <arg n="0">a decreased transcription of the curlin encoding csgA gene</arg>
                    <arg n="1">the negative effect of the cpxA mutation</arg>
                </example>
                <example src="EGRAM" no="304">
                    <text>We show that the negative effect of the cpxA mutation on biofilm formation may have resulted from a decreased transcription of the curlin encoding csgA gene.</text>
                    <arg n="0">a decreased transcription of the curlin encoding csgA gene</arg>
                    <arg n="1">the negative effect of the cpxA mutation</arg>
                </example>
                <example src="EGRAM" no="305">
                    <text>We show that the negative effect of the cpxA mutation on biofilm formation may result from a decreased transcription of the curlin encoding csgA gene.</text>
                    <arg n="0">a decreased transcription of the curlin encoding csgA gene</arg>
                    <arg n="1">the negative effect of the cpxA mutation</arg>
                </example>
                <example src="EGRAM" no="306">
                    <text>We show that the negative effect of the cpxA mutation on biofilm formation resulted from a decreased transcription of the curlin encoding csgA gene.</text>
                    <arg n="0">a decreased transcription of the curlin encoding csgA gene</arg>
                    <arg n="1">the negative effect of the cpxA mutation</arg>
                </example>
                <example src="EGRAM" no="307">
                    <text>We show that the negative effect of the cpxA mutation on biofilm formation results from a decreased transcription of the curlin encoding csgA gene.</text>
                    <arg n="0">a decreased transcription of the curlin encoding csgA gene</arg>
                    <arg n="1">the negative effect of the cpxA mutation</arg>
                </example>
                <example src="EGRAM" no="308">
                    <text>We speculated that this has been shown to be the result of the expression of isoforms of Nrf1 in mast cells.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="EGRAM" no="309">
                    <text>We speculated that this is observed to be the result of the expression of isoforms of Nrf1 in mast cells.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="EGRAM" no="310">
                    <text>We speculated that this is the result of the expression of isoforms of Nrf1 in mast cells.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="EGRAM" no="311">
                    <text>We speculated that this may be the result of the expression of isoforms of Nrf1 in mast cells.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
